A carregar...

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

The results of our third trial on epicutaneous allergen-specific immunotherapy (EPIT) will be presented and discussed in the context of our previous trials. This monocentric, placebo-controlled, double-blind phase I/IIa trial included 98 patients with grass pollen rhinoconjunctivitis. Prior to the p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy
Main Authors: Senti, G, von Moos, S, Tay, F, Graf, N, Johansen, P, Kündig, T M
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654258/
https://ncbi.nlm.nih.gov/pubmed/25704072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12600
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!